相关实验视频

Updated: Jul 21, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

新辅助免疫疗法:一个有前途的新护理标准

Emma Boydell¹, Jose L Sandoval¹, Olivier Michielin¹

¹University Hospital of Geneva, 1205 Geneva, Switzerland.

International journal of molecular sciences

|July 29, 2023

概括

新辅助免疫疗法对各种癌症有前途,但仅对一部分患者有益. 识别预测性生物标志物对于选择适合此术前治疗的候选人至关重要.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
生物标志物发现发现

背景情况:

新辅助免疫疗法是一种术前治疗策略,在增强对各种恶性瘤的免疫反应方面表现有前途.
有FDA批准的新辅助免疫疗法方案用于三阴性乳腺癌和早期非小细胞肺癌,改善病理反应和无事件生存.
然而,目前的新辅助免疫治疗效益仅在一小部分患者中观察到,这凸显了改善患者选择的必要性.

研究的目的:

审查早期癌症中新辅助免疫治疗的潜在预测生物标志物.
探索三阴性乳腺癌,膀癌,黑色素瘤,非小细胞肺癌,结直肠癌和胃癌中的生物标志物.
讨论生物标志物识别,验证和临床实施方面的挑战.

主要方法:

从转移性环境到新辅助性环境的预测生物标志物的文献综述和推断.
检查已确定的生物标志物,如PD-L1,不匹配修复缺陷和瘤突变负担.
确定和讨论潜在的早期疾病特异性生物标志物.

主要成果:

已经确立的生物标志物如PD-L1,不匹配修复缺陷和瘤突变负担被探索为预测新辅助免疫疗法反应的预测因素.
考虑了针对早期疾病的潜在新生物标志物.
在确定新辅助免疫疗法可靠的预测生物标志物方面存在重大挑战.

结论:

准确选择患者接受新辅助免疫疗法至关重要,需要强大的预测生物标志物.
标准化协议和指导方针对于这些生物标志物的验证和临床实施至关重要.
需要进一步的研究来识别和验证可优化新辅助免疫疗法在各种恶性瘤中的疗效的生物标志物.

关键词:

在NSCLCLC中,我们可以看到NSCLCLC.胃癌胃癌是一种胃癌.免疫疗法免疫疗法黑色素瘤是一种黑色素瘤.这是一种新辅助剂.预测性的生物标志物尿路细胞癌是什么意思

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...